Alta Fox Corrects the Record Regarding Daktronics’ Misleading Statements
Alta Fox Capital Management, Daktronics' (NASDAQ: DAKT) largest shareholder with 11.7% ownership, has issued a statement addressing what they describe as misleading claims from the company. Alta Fox clarifies their position regarding their convertible promissory note and reiterates their belief that Daktronics can achieve approximately $40 per share and ~100% upside by FY28.
The investor criticizes Daktronics' governance practices, including a staggered Board, poison pill, and alleged nepotism. Alta Fox's equity position is worth nearly $114 million once converted, representing about 5 times the shares held by the entire Board. The firm plans to nominate independent director candidates and emphasizes their right to call a special shareholder meeting.
Alta Fox Capital Management, il maggiore azionista di Daktronics (NASDAQ: DAKT) con una partecipazione dell'11,7%, ha rilasciato una dichiarazione in risposta a ciò che definiscono affermazioni fuorvianti da parte dell'azienda. Alta Fox chiarisce la propria posizione riguardo alla loro nota convertibile e ribadisce la convinzione che Daktronics possa raggiungere circa $40 per azione con un potenziale di guadagno di circa il 100% entro la fine dell'anno fiscale 2028.
L'investitore critica le pratiche di governance di Daktronics, inclusi un Consiglio di Amministrazione scaglionato, una pillola avvelenata e presunti nepotismi. La posizione azionaria di Alta Fox vale quasi 114 milioni di dollari una volta convertita, rappresentando circa 5 volte le azioni detenute dall'intero Consiglio. L'azienda prevede di nominare candidati indipendenti per il Consiglio di Amministrazione e sottolinea il proprio diritto di convocare un'assemblea straordinaria degli azionisti.
Alta Fox Capital Management, el mayor accionista de Daktronics (NASDAQ: DAKT) con una participación del 11,7%, ha emitido un comunicado abordando lo que describen como afirmaciones engañosas por parte de la empresa. Alta Fox aclara su posición respecto a su nota convertible y reitera su creencia de que Daktronics puede alcanzar aproximadamente $40 por acción y un incremento de alrededor del 100% para el año fiscal 2028.
El inversor critica las prácticas de gobernanza de Daktronics, incluyendo una Junta escalonada, una píldora envenenada y el presunto nepotismo. La posición de capital de Alta Fox vale aproximadamente 114 millones de dólares una vez convertida, representando cerca de 5 veces las acciones que posee toda la Junta. La firma planea nominar candidatos a directores independientes y enfatiza su derecho a convocar una reunión extraordinaria de accionistas.
알타 폭스 캐피털 매니지먼트는 다크트로닉스(NASDAQ: DAKT)의 최대 주주로, 11.7%의 지분을 보유하고 있으며, 회사의 오해의 소지가 있는 주장에 대해 성명을 발표했습니다. 알타 폭스는 전환사채에 대한 자신의 입장을 명확히 하고 다크트로닉스가 $40 per share에 도달할 수 있으며 FY28까지 약 100%의 상승 잠재력이 있다고 믿는다고 재확인했습니다.
투자는 다크트로닉스의 지배구조 관행, 즉 격주 이사회, 독소조항 및 자녀채용 주장을 비판합니다. 알타 폭스의 지분은 전환 시 거의 1억 1400만 달러에 달하며, 전체 이사회가 보유한 주식의 약 5배에 해당합니다. 해당 회사는 독립 이사 후보를 지명할 계획이며, 특별 주주 총회를 소집할 권리를 강조하고 있습니다.
Alta Fox Capital Management, le plus grand actionnaire de Daktronics (NASDAQ: DAKT) avec une participation de 11,7 %, a publié une déclaration répondant à ce qu'ils décrivent comme des allégations trompeuses de la part de l'entreprise. Alta Fox clarifie sa position concernant sa note convertible et réitère sa conviction que Daktronics peut atteindre environ $40 par action et un potentiel de hausse d'environ 100% d'ici l'exercice 2028.
L'investisseur critique les pratiques de gouvernance de Daktronics, y compris un Conseil d'Administration échelonné, une pilule empoisonnée et un prétendu népotisme. La position en actions d'Alta Fox vaut près de 114 millions de dollars une fois convertie, représentant environ 5 fois les actions détenues par l'ensemble du Conseil. La société prévoit de nommer des candidats directeurs indépendants et souligne son droit de convoquer une assemblée générale extraordinaire des actionnaires.
Alta Fox Capital Management, der größte Aktionär von Daktronics (NASDAQ: DAKT) mit einem Anteil von 11,7%, hat eine Erklärung abgegeben, um auf das zu reagieren, was sie als irreführende Behauptungen des Unternehmens bezeichnen. Alta Fox erläutert seine Position zu ihrer wandelbaren Schuldverschreibung und bekräftigt ihren Glauben, dass Daktronics etwa $40 pro Aktie erreichen und bis zum Geschäftsjahr 2028 einen Anstieg von rund 100% erzielen kann.
Der Investor kritisiert die Governance-Praxis von Daktronics, einschließlich eines gestaffelten Vorstands, einer vergifteten Pille und angeblichen Nepotismus. Die Eigenkapitalposition von Alta Fox ist nach der Umwandlung fast 114 Millionen Dollar wert und entspricht etwa dem Fünffachen der Aktien, die der gesamte Vorstand hält. Das Unternehmen plant, unabhängige Direktorenkandidaten zu nominieren, und betont sein Recht, eine außerordentliche Hauptversammlung einzuberufen.
- Alta Fox's previous price target of $16.23 has been exceeded with stock currently trading at ~$19
- Company shows potential for $40 per share value by FY28 through proposed reforms
- Serious governance issues including staggered Board and poison pill
- Long-term underperformance during current CEO's tenure
- Alleged nepotism in executive ranks
- Board's resistance to shareholder-friendly recommendations
Insights
Alta Fox's escalating activist campaign against Daktronics represents a significant development with potentially major implications for shareholders. The fund's
The ongoing tension between Alta Fox and current management over the convertible note and board composition could lead to a proxy fight, which typically creates share price volatility. While Alta Fox's previous
The governance issues raised by Alta Fox are substantial and systemic. A staggered board structure, combined with a poison pill and alleged nepotism in executive ranks, represents outdated corporate governance practices that typically lead to shareholder value destruction. The
The board's defensive response to Alta Fox's legitimate shareholder rights to nominate directors and call special meetings suggests an entrenched mentality resistant to change. Modern governance best practices favor annual director elections, strong shareholder rights and independent oversight - all apparently lacking at Daktronics. This governance discount likely contributes to valuation multiples below peers and could represent a significant opportunity for value creation if addressed.
Publicly Clarifies Alta Fox’s Stance on its Convertible Promissory Note
Reiterates its Belief that Daktronics Can Achieve
“Yesterday, we released a detailed presentation outlining the serious governance issues at Daktronics, including long-term underperformance during Chairman and CEO Reece Kurtenbach’s tenure, a misalignment of interests between the Board of Directors (the “Board”) and shareholders, and rampant nepotism in the executive ranks.
Instead of responding to the governance concerns raised by its largest shareholder, Daktronics has tried to paint Alta Fox as a bloodthirsty creditor, somehow misaligned with Daktronics' equity investors. This is a weak argument that investors will not be duped into believing. Let us set the record straight:
-
Alta Fox has an equity position in Daktronics worth nearly
once converted, or$114 million 11.7% of the Company’s outstanding shares.1 To insinuate that we are not aligned with shareholders is absurd, considering we are the Company’s largest shareholder and own ~5x the number of shares held by the entire Board.
-
The Company neglects to mention that Alta Fox has sought further governance enhancements as part of any agreement to retire our convertible promissory note. Over the years, Daktronics has failed to take our shareholder-friendly recommendations and highly qualified director candidates seriously. Unfortunately, this is unsurprising for a Company that abides by worst-in-class governance practices, including a staggered Board, poison pill and nepotism. Despite its claims of engaging in good faith, the Company never presented us with any proposed framework or offer. The Company merely suggested retiring the note early, without specifying a value, which Alta Fox noted could be a way to avoid diluting existing shareholders. We have consistently been a better barometer of Daktronics’ fair value than the current Board, and we would never accept a discount to what we believe the Company is worth.
-
As a shareholder, we have an unassailable right to put up directors for election at an annual meeting and to call a special meeting of shareholders. The Company’s claim in its December 11th press release that we have tried to "intimidate" the Board by stating our intention to nominate highly qualified, independent director candidates is not only delusional, but also speaks to the Board’s extreme level of entrenchment and the insular culture it has perpetuated.
-
Counter to what Daktronics claims, Alta Fox’s May 2023 post that stated our belief that shares could triple to
~ has proven prescient: Daktronics currently trades at$16.23 ~ .2 In the 19 months since that post, we have continued to study the business and speak to industry experts and ex-employees. We now believe the Company’s potential upside is far greater than we originally realized, and that Daktronics’ significant governance discount can be addressed, as we highlighted in our December 10th presentation. Perhaps this is news to the Board or its advisors, but facts and price targets can change over time.$19
-
We clearly see more potential value in Daktronics than the current Board or management do. As outlined in our December 10th presentation, we believe there is a path to achieving
per share and ~$40 100% upside by FY28 through governance reforms, the addition of new directors who possess expertise in corporate governance and investor communication, and operational improvements.
It is disturbing to see Daktronics attempt to smear Alta Fox’s reputation with other shareholders after we stepped in to provide necessary rescue capital to the Company in its time of need and have dedicated more than two years to patiently advocating for improvements to the Company’s governance, financial management practices and performance.
As much as the Daktronics Board may try to evade it, accountability is coming. Alta Fox intends to utilize our full voting power as equity investors to benefit all stakeholders. We look forward to providing shareholders an opportunity to elect highly qualified directors so that Daktronics can realize its full potential.”
***
Alta Fox encourages Daktronics stakeholders to visit www.FixDaktronics.com to learn more about our path to
About Alta Fox
Founded in 2018 by Connor Haley, Alta Fox is a
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
The information herein contains “forward-looking statements.” Specific forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts and include, without limitation, words such as “may,” “will,” “expects,” “intends,” “believes,” “anticipates,” “plans,” “estimates,” “projects,” “potential,” “targets,” “forecasts,” “seeks,” “could,” “should” or the negative of such terms or other variations on such terms or comparable terminology. Similarly, statements that describe our objectives, plans or goals are forward-looking. Forward-looking statements relate to future events or future performance and involve known and unknown risks, uncertainties, and other factors that may cause actual results, levels of activity, performance or achievements or those of the industry to be materially different from those expressed or implied by any forward-looking statements. Daktronics, Inc., a
Certain statements and information included herein have been sourced from third parties. Alta Fox does not make any representations regarding the accuracy, completeness or timeliness of such third party statements or information. Except as may be expressly set forth herein, permission to cite such statements or information has neither been sought nor obtained from such third parties. Any such statements or information should not be viewed as an indication of support from such third parties for the views expressed herein.
_________________________
1 Based on Daktronics’ share price of
2 Daktronics closed at
View source version on businesswire.com: https://www.businesswire.com/news/home/20241211772129/en/
For Shareholders:
Alta Fox Investor Relations
ir@altafoxcapital.com
or
Okapi Partners
Bruce Goldfarb / Chuck Garske, 212-297-0720
info@okapipartners.com
For Media:
Longacre Square Partners
Kate Sylvester / Bela Kirpalani, 646-386-0091
altafox@longacresquare.com
Source: Alta Fox Capital Management, LLC
FAQ
What is Alta Fox's ownership stake in Daktronics (DAKT)?
What is Alta Fox's price target for DAKT stock by FY28?
What governance issues has Alta Fox identified at Daktronics (DAKT)?